TRANS (+/-)-2-((R)-1-PHENYLETHYLAMINO)CYCLOPENTANOL, 95.0%, 1g

2-(4-hydroxy-6-methylpyrimidin-5-yl)acetic acid, 95.0%, 250mg

4-((3-Hydroxypropyl)amino)benzonitrile, 98%, 100mg

GC capillary column ROTI®Cap-1, 10 m, 0.53 mm, 5.00 µm, 1 Piece(s)

(S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 97%, 200g

(S)-1,1,1-Trifluoro-2-hexylamine, 1g

8-Bromo-6-chloroquinoline, 95.0%, 1g

Ethyl 1,3-Dithiane-2-carboxylate>98.0%(GC)1g

3-(Cyclopropylamino)pyrrolidine-2,5-dione, 95%, 100mg

3-Ethoxy-2,2-dimethyl-3-oxopropanoic acid, 95.0%, 1g

tert-Butyl 8-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 250mg

Undec-10-enoic acid, 95.0%, 1kg

3,3-Difluoro-4,4-dimethyl-pyrrolidine;hydrochloride, 98%, 25g